Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case-Control Study

• Main Authors: Maria Albanese (Author), Giulia Marrone (Author), Agostino Paolino (Author), Manuela Di Lauro (Author), Francesca Di Daniele (Author), Carlo Chiaramonte (Author), Cartesio D'Agostini (Author), Annalisa Romani (Author), Alessandro Cavaliere (Author), Cristina Guerriero (Author), Andrea Magrini (Author), Nicola Biagio Mercuri (Author), Nicola Di Daniele (Author), Annalisa Noce (Author)
• Format: Book
• Published: MDPI AG, 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ultramicronized palmitoylethanolamide (um-PEA), a compound with antioxidant, anti-inflammatory and neuroprotective properties, appears to be a potential adjuvant treatment for early stages of Coronavirus disease 2019 (COVID-19). In our study, we enrolled 90 patients with confirmed diagnosis of COVID...